Details for New Drug Application (NDA): 212223
✉ Email this page to a colleague
The generic ingredient in CAPTOPRIL is captopril; hydrochlorothiazide. There are fifteen drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the captopril; hydrochlorothiazide profile page.
Summary for 212223
Tradename: | CAPTOPRIL |
Applicant: | Seton Pharms |
Ingredient: | captopril |
Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 212223
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 12.5MG | ||||
Approval Date: | Oct 30, 2019 | TE: | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 25MG | ||||
Approval Date: | Oct 30, 2019 | TE: | RLD: | No |
Profile for product number 003
Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 50MG | ||||
Approval Date: | Oct 30, 2019 | TE: | RLD: | No |
Complete Access Available with Subscription